Baker, Stephen

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 16,316

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 3,791

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 1,337

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., et al. (2022) · Nature

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,146

SARS-CoV-2 evolution during treatment of chronic infection

Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,097

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Collier, D. A., Ferreira, I. A. T. M., Kotagiri, P., Datir, R. P., Lim, E. Y., Touizer, E., Meng, B., Abdullahi, A., The CITIID-NIHR BioResource COVID-19 Collaboration, Principal Investigators, et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 751

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., Silacci-Fregni, C., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 728

Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R.-M. V., Novotney, A., Wool, E. E., Ikuta, K. S., Vongpradith, A., Rogowski, E. L. B., Doxey, M., et al. (2024) · The Lancet Infectious Diseases

Pneumonia and Respiratory InfectionsRespiratory viral infections research

Cited by 596

Salmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever

Dougan, G., & Baker, S. (2014) · Annual Review of Microbiology

Salmonella and Campylobacter epidemiologyBacterial Genetics and Biotechnology

Cited by 338

A thermostable, closed SARS-CoV-2 spike protein trimer

Xiong, X., Qu, K., Ciazynska, K. A., Hosmillo, M., Carter, A. P., Ebrahimi, S., Ke, Z., Scheres, S. H. W., Bergamaschi, L., Grice, G. L., et al. (2020) · Nature Structural & Molecular Biology

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 313

The global burden and epidemiology of invasive non-typhoidal Salmonella infections

Balasubramanian, R., Im, J., Lee, J.-S., Jeon, H. J., Mogeni, O. D., Kim, J. H., Rakotozandrindrainy, R., Baker, S., & Marks, F. (2019) · Human Vaccines & Immunotherapeutics

Salmonella and Campylobacter epidemiologyBacterial Infections and Vaccines

Cited by 261

The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa

Park, S. E., Pham, D. T., Boinett, C., Wong, V. K., Pak, G. D., Panzner, U., Espinoza, L. M. C., von Kalckreuth, V., Im, J., Schütt-Gerowitt, H., et al. (2018) · Nature Communications

Salmonella and Campylobacter epidemiologyAntibiotic Resistance in Bacteria

Cited by 120

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

Needham, E. J., Ren, A. L., Digby, R. J., Norton, E. J., Ebrahimi, S., Outtrim, J. G., Chatfield, D. A., Manktelow, A. E., Leibowitz, M. M., Newcombe, V. F. J., et al. (2022) · Brain

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 90

The genomic epidemiology of multi-drug resistant invasive non-typhoidal Salmonella in selected sub-Saharan African countries

Park, S. E., Pham, D. T., Pak, G. D., Panzner, U., Maria Cruz Espinoza, L., von Kalckreuth, V., Im, J., Mogeni, O. D., Schütt-Gerowitt, H., Crump, J. A., et al. (2021) · BMJ Global Health

Salmonella and Campylobacter epidemiologyAntibiotic Resistance in Bacteria

Cited by 50

The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal

Malla, S., Dumre, S. P., Shakya, G., Kansakar, P., Rai, B., Hossain, A., Nair, G. B., Albert, M. J., Sack, D., Baker, S., et al. (2014) · BMC Public Health

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 44

Bacteremia Among Febrile Patients Attending Selected Healthcare Facilities in Ibadan, Nigeria

Popoola, O., Kehinde, A., Ogunleye, V., Adewusi, O. J., Toy, T., Mogeni, O. D., Aroyewun, E. O., Agbi, S., Adekanmbi, O., Adepoju, A., et al. (2019) · Clinical Infectious Diseases

Bacterial Identification and Susceptibility TestingSalmonella and Campylobacter epidemiology

Cited by 35